BioBlast Pharma
Tel Aviv
About BioBlast Pharma
Bio Blast Pharma, a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is headquartered in Tel Aviv, Israel. The board has approved the nomination of the following individuals to serve as members of the Board, effective on July 31: Gili Cohen; Eyal Gibor; Tomer Yossef; and Ran Weinstock. All the new members of the board qualify as independent directors under applicable Nasdaq rules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $4.8M
- Funding stage: IPO
- Last round: Series Unknown (Feb 2014)
- Ticker: nasdaq:ORPN
- Website: bioblast-pharma.com
- Phone: +972 72-240-9060
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/bioblast-pharma-3698531 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.